This is a summary of the European public assessment report (EPAR) for Omidria. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Omidria. For practical information about using Omidria, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
### Therapeutic indication Omidria is indicated in adults for maintenance of intraoperative mydriasis, prevention of intraoperative miosis and reduction of acute postoperative ocular pain in intraocular lens replacement surgery.
Therapeutic Area (MeSH)
ATC Code
S01
ATC Item
眼科用药
Pharmacotherapeutic Group
Ophthalmologicals
Active Substance (Summary)
INN / Common Names
EMA Name
Omidria
Medicine Name
Omidria
Aliases
N/ANo risk management plan link.
